GM-CSF Antibodies and Peripheral Treg Cells as Potential Markers of Disease Activity to Guide Therapeutic Decisions in Pediatric IBD
Piyali Ray(The University of Texas Health Science Center at Houston), Marc Rhoads J(The University of Texas Health Science Center at Houston), Lee A. Denson(Cincinnati Children's Hospital Medical Center), Cynthia Bell(World Health Organization - Pakistan), Thomas K. Hoang(The University of Texas Health Science Center at Houston), Nicole Y. Fatheree(The University of Texas Health Science Center at Houston), Yuying Liu(South China University of Technology), Fernando A. Navarro(South Carolina Department of Education)
Cited by 0
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
|Nature Genetics|2011|1.4k
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
|Journal of Clinical Investigation|2014|532